Immunohistochemical evaluation of Fhit protein expression in oral squamous cell carcinomas

Journal of Oral Pathology and Medicine

Volumn 28, Issue 10, 1999, Pages 433-437

  Van Heerden, W F P ^b   Swart, T J P ^c   Van Heerden, M B ^c   Van Rensburg, E J ^c   Engelbrecht, S ^c   Dreyer, L ^c   Huebner, K ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Faculty of Education   (South Africa)

^c NONE

Author keywords

Chromosome 3; Fhit; Immunohistochemistry; Oral cancer; Tumour suppressor genes

Indexed keywords

EID: 0033230366     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1999.tb02102.x     Document Type: Article

References (23)

1. JOHNSON NW. A global view of the epidemiology of oral cancer. In: JOHNSON NW, ed. Risk markers for oral diseases. Vol 2: Oral cancer, detection of patients and lesions at risk. Cambridge: Cambridge University Press, 1991; 1-26.
2. SITAS F, TERBLANCHE M, MADHOO J. National Cancer Registry of South Africa. Incidence and geographical distribution of histologically diagnosed cancer in South Africa, 1990 & 1991. South African Institute for Medical Research, 1996.
3. SITAS F, BLAAUW D, TERBLANCHE M, MADHOO J, CARRARA H. National Cancer Registry of South Africa. Incidence of histologically diagnosed cancer in South Africa, 1992. South African Institute for Medical Research, 1997.
4. OHTA M, INOUE H, COTTICELLI MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site renal carcinoma-associated 1(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996; 84: 587-97.
5. DRUCK T, HADACZEK P, FU T-B, et al. Structure and expression of human FHIT gene in normal and tumor cells. Cancer Res 1997; 57: 504-12.
6. 3 triphosphate hydrolase. Biochemistry 1996; 35: 11529-35.
7. SMEETS DFCM, SCHERES JMJC, HUSTINIX TWJ. The most common fragile site in man is 3p14. Hum Genet 1986; 72: 215-20.
8. ROZ L, WU CL, PORTER S, et al. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res 1996; 84: 587-97.
9. NAWROZ H, VAN DER RIET P, HRUBAN RH, KOCH W, RUPPERT MJ, SIDRANSKY D. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994; 54: 1152-5.
10. VIRGILIO L, SHUSTER M, GOLLIN SM, et al. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 1996; 93: 9770-5.
11. MAO L, FAN YH, LOTAN R, HONG WK. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 1996; 56: 5128-33.
12. KISIELEWSKI AE, XIAO GH, LIU SC, et al. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck. Oncogene 1998; 17: 83-91.
13. HUEBNER K, GARRISON PN, BARNES LD, CROCE CM. The role of the FRA3B/ FHIT locus in cancer. Ann Rev Genet 1998; 32: 7-31.
14. HUEBNER K, SOZZI G, BRENNER C, PIEROTTI MA, CROCE CM. Fhit loss in lung cancer: diagnostic and therapeutic implications. Adv Oncol 1999; in press.
15. SOZZI G, PASTORINO U, MOIRAGHI L, et al. Loss of FHIT expression in lung cancer and preinvasive bronchial lesions. Cancer Res 1998; 58: 5032-7.
16. TOMIZAWA Y, NAKAJIMA T, KOHNO T, SAITO R, YAMAGUCHI N, YOKOTA J. Clinicopathological significance of Fhit protein expression in stage 1 non-small cell lung carcinoma. Cancer Res 1998; 58: 5478-83.
17. GREENSPAN DL, CONNOLLY DC, WU R, et al. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 1997; 57: 4692-8.
18. XIAO GH, JIN F, KLEIN-SZANTO AJ, GOODROW TL, LINEHAN MW, YEUNG RS. The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers. Am J Pathol 1997; 151: 1541-7.
19. HADACZEK P, SIPRASHVILI Z, MARKIEWSKI M, et al. Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res 1998; 58: 2946-51.
20. HUEBNER K, GARRISON PN, BARNES LD, CROCE CM. The role of the FRA3B/ FHIT locus in cancer. Ann Rev Genet 1998; 32: 7-31.
21. SIPRASHVILI Z, SOZZI G, BARNES LD, et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci USA 1997; 94: 13771-6.
22. BAFFA R, VERONESE ML, SANTORO R, et al. Loss of FHIT expression in gastric carcinoma. Cancer Res 1998; 58: 4708-14.
23. LE BEAU MM, DRABKIN H, GLOVER TW, et al. An FHIT tumor suppressor gene. Genes Chromosomes Cancer 1998; 21: 281-9.